Search research articles
Contact Us
Filters
Showing results (251-260 of 303) with videos related to
Page
of 31
Sort By:
Progress in Transplantation (Aliso Viejo, Calif.)
|
November 16, 2023
Report From a Multidisciplinary Symposium on the Future of Living Kidney Donor Transplantation
Thomas G Peters, John J Fung, Janet Radcliffe-Richards, et al.
The Journal of Biological Chemistry
|
December 15, 2019
Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer
Mukul Sherekar, Sae-Won Han, Rodolfo Ghirlando, et al.
The Journal of Biological Chemistry
|
June 5, 2025
Biophysical and structural analysis of KRAS switch-II pocket inhibitors reveals allele-specific binding constraints
Patrick Alexander, Albert H Chan, Dana Rabara, et al.
American Journal of Medical Genetics. Part A
|
January 19, 2010
What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers
Joseph L Kissil, Jaishri O Blakeley, Rosalie E Ferner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2019
Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study
Khoan Vu, Chi-Heng Wu, Chen-Yen Yang, et al.
The Journal of Biological Chemistry
|
January 18, 2024
Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by <sup>31</sup>P NMR
Alok K Sharma, Jun Pei, Yue Yang, et al.
Plos One
|
June 5, 2012
Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas
Keiko Shoji, Katsutoshi Oda, Tomoko Kashiyama, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 23, 2023
Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization
Lucy C Young, Ruby Goldstein de Salazar, Sae-Won Han, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
April 26, 2021
Sensitivity of Oncogenic KRAS-Expressing Cells to CDK9 Inhibition
Lick Pui Lai, Viviane Brel, Kanika Sharma, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
Modulation of the 14-3-3σ/C-RAF "auto"inhibited complex by molecular glues
Markella Konstantinidou, Holly R Vickery, Marloes A M Pennings, et al.
Page
of 31
Search research articles
Search
Showing results (251-260 of 303) with videos related to
Sort By:
Page
of 31
Progress in Transplantation (Aliso Viejo, Calif.)
|
November 16, 2023
Report From a Multidisciplinary Symposium on the Future of Living Kidney Donor Transplantation
Thomas G Peters, John J Fung, Janet Radcliffe-Richards, et al.
The Journal of Biological Chemistry
|
December 15, 2019
Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer
Mukul Sherekar, Sae-Won Han, Rodolfo Ghirlando, et al.
The Journal of Biological Chemistry
|
June 5, 2025
Biophysical and structural analysis of KRAS switch-II pocket inhibitors reveals allele-specific binding constraints
Patrick Alexander, Albert H Chan, Dana Rabara, et al.
American Journal of Medical Genetics. Part A
|
January 19, 2010
What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers
Joseph L Kissil, Jaishri O Blakeley, Rosalie E Ferner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2019
Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study
Khoan Vu, Chi-Heng Wu, Chen-Yen Yang, et al.
The Journal of Biological Chemistry
|
January 18, 2024
Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by <sup>31</sup>P NMR
Alok K Sharma, Jun Pei, Yue Yang, et al.
Plos One
|
June 5, 2012
Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas
Keiko Shoji, Katsutoshi Oda, Tomoko Kashiyama, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 23, 2023
Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization
Lucy C Young, Ruby Goldstein de Salazar, Sae-Won Han, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
April 26, 2021
Sensitivity of Oncogenic KRAS-Expressing Cells to CDK9 Inhibition
Lick Pui Lai, Viviane Brel, Kanika Sharma, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
Modulation of the 14-3-3σ/C-RAF "auto"inhibited complex by molecular glues
Markella Konstantinidou, Holly R Vickery, Marloes A M Pennings, et al.
Page
of 31